XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net income $ 100,109 $ 102,962
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation & amortization 7,350 7,722
(Increase) decrease in value of equity securities (1,003) 11,408
Amortization of securities, net 3,826 3,835
Accretion of purchased loans (2,772) (3,172)
Share-based compensation 2,275 2,507
Gain on assets (207) (146)
Provision for credit losses on loans 5,500 1,200
Recovery of credit losses on unfunded commitments (1,000) 0
Deferred income tax effect 1,567 176
Increase in cash value of life insurance (1,195) (1,104)
Originations of mortgage loans held for sale (119,379) (90,465)
Proceeds from sales of mortgage loans held for sale 126,012 66,655
Changes in assets and liabilities:    
Accrued interest receivable (63) 459
Other assets (21,169) (99)
Accrued interest payable and other liabilities 47,692 16,010
Net cash provided by operating activities 147,543 117,948
Investing Activities    
Net increase in federal funds sold (100) 0
Net (increase) decrease in loans, excluding purchased loans (99,450) 43,894
Proceeds from maturities of investment securities – available-for-sale 73,448 330,539
Proceeds from maturities of investment securities – held-to-maturity 1,444 1,378
(Purchase) redemption of other investments (2,176) 5,239
Proceeds from foreclosed assets held for sale 306 157
Proceeds from sale of SBA loans 2,949 2,337
Purchases of premises and equipment, net (1,682) (2,404)
Return of investment on cash value of life insurance 280 0
Net cash (used in) provided by investing activities (24,981) 381,140
Financing Activities    
Net increase (decrease) in deposits 78,419 (493,317)
Net increase in securities sold under agreements to repurchase 34,022 7,596
Decrease in FHLB and other borrowed funds (1,400,250) 0
Increase in FHLB and other borrowed funds 1,400,000 0
Proceeds from exercise of stock options 671 86
Repurchase of common stock (24,152) (13,540)
Dividends paid on common stock (36,227) (36,649)
Net cash provided by (used in) financing activities 52,483 (535,824)
Net change in cash and cash equivalents 175,045 (36,736)
Cash and cash equivalents – beginning of year 1,000,213 724,790
Cash and cash equivalents – end of period $ 1,175,258 $ 688,054